- Country: USA
- Summary: Notice of Intent to Sole Source - Hematology Analyzer Naval Health Clinic Hawaii
- UST Ref No: 77037801
- Deadline: 20 Jan 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: HT941022N0009
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
Reference#: HT941023N0009
The Defense Health Agency Contracting Activity (DHACA) Western Markets - Contracting Division (WM-CD) on behalf of Naval Health Clinic Hawaii (NHCH) intends to negotiate on a sole source basis (IAW FAR 13.501(a), Only One Responsible Source. The proposed source is Sysmex America, Inc., 577 Aptakisic Road Lincolnshire, IL 60069-4325.
EquipmentThis is a supply requirement for two (2) hematology analyzers, reagents, quality control, maintenance, and consumables for NHCH. One analyzer will be located at Branch Health Clinic Makalapa and one analyzer will be located at Branch Health Clinic Kaneohe Bay.
Each analyzer shall meet the following minimum requirements:
Must be capable of performing complete blood count (CBC), WBC, cell differential, blood film differential, reticulocyte (retic) analysis and nucleated red blood cell (NRBC) with 6-part differential, including FDA Approved Immature Granulocyte (IG) parameter Must be a single model platform Must be capable of performing general hematology testing for a minimum annual workload of 7,800 specimens for Makalapa and a minimum workload of 3,900 for Kaneohe Bay Must be capable of processing a minimum of 60 samples per hour Must be capable of general hematology testing for the management of chronic kidney disease (CKD) and anemia management. Must be capable of advanced measures of hematopoiesis, eliminating the need for whole blood count (WBC) corrections. Testing for CKD shall utilize a non- cyanide reagent for Hemoglobin (Hgb) Must be utilized for early detection of sepsis, inflammatory response or myeloproliferative disorders Must be able to test small aspiration volumes of less than 101 μl Must provide real-time results with rerun/reflex testing capabilities Must be capable of creating scatter plots of WBC differential populations, NRBC and retic populations Must be able to report RBC and WBC data to three (3) decimal places Must be able to qualitatively indic... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNotice of Intent to Sole Source - Hematology Analyzer Naval Health Clinic Hawaii - USA Tender
The DEPT OF DEFENSE, a Government sector organization in USA, has announced a new tender for Notice of Intent to Sole Source - Hematology Analyzer Naval Health Clinic Hawaii. This tender is published on USARFP under UST Ref No: 77037801 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-01-20.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
